Reuters is first report The FDA approved Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug that treats a fatty liver disease called nonalcoholic steatohepatitis (NASH). This approval is the first of its kind.
healthy
March 14, 2024, 2:54 pm 1 minute
market impact
The company’s shares surged 24% in after-hours trading.
Article tags
Topics of interest: healthy
type: Reuters Best
department: Pharmaceuticals and Healthcare
area: America
nation: USA
Winning type: speed
Story type: exclusive/exclusive report
media type: text
Customer Impact: important national stories